Rare copy number variations containing genes involved in RASopathies: deletion of SHOC2 and duplication of PTPN11

Molecular Cytogenetics

Zhi-Ping Tan³  Yi-Feng Yang³  Jian Wang³  Tian-Li Zhao²  Xin Zhu¹  Jin-Lan Chen² 

[1] Department of Gynecology and Obstetrics, Xiangya Hospital of Central South University, Changsha, China;Department of Cardiothoracic Surgery, the 2nd Xiangya Hospital of Central South University, Changsha, China;Clinical Center for Gene Diagnosis and Therapy of State Key Laboratory of Medical Genetics, the Second Xiangya Hospital, Central South University, Changsha, China

关键词: Congenital heart defect;    CNV;    Copy number variation;    10q25.2 deletion;    12q24 duplication;    PTPN11;    SHOC2;    RASopathy;    Noonan syndrome;   

Others  :  1150115
DOI  :  10.1186/1755-8166-7-28

 received in 2014-01-24, accepted in 2014-03-15,  发布年份 2014

【 摘 要 】

Background

RASopathies are a group of disorders related to Noonan syndrome that with dysregulated RAS-mitogen-activated protein kinase (MAPK) signaling pathway. Noonan syndrome (NS, OMIM# 163950) is a both phenotypically and genotypically variable disorder. We and other researchers have demonstrated that copy number variations underlie a small percentage of patients with RASopathies.

Results

In a cohort of 12 clinically characterized patients with congenital heart defect (CHD) and features suggestive of Noonan syndrome or Noonan like syndrome without known causative gene mutation, we performed an Illumina SNP-array analysis to identify the pathogenic copy number variations (Human660W-Quad Chip, Beadstation Scanner and GenomeStudio V2011 software).

We identifed two rare copy number variations harboring genes involved in RAS- MAPK signaling pathway of RASopathy. One is a 24 Mb duplication of 12q24.1-24.3 containing PTPN11 and the other is a 183 kb deletion of 10q25.2 including SHOC2. The SNP-array results were further validated by quantitative PCR (qPCR). This is might be the first report suggesting that haploinsufficiency of SHOC2 can result in a RASopathy-like phenotype.

Conclusions

Our findings provide additional support that copy number variations containing disease-causing genes of RAS/MAPK pathway play a minor role in RASopathies or related disorders. We recommend the use of microarrays in Noonan syndrome like patients without identified mutations in the causative genes.

【 授权许可】

   
2014 Chen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Rauen KA: The RASopathies. Annu Rev Genomics Hum Genet 2013, 14:355-369.
• [2]Roberts AE, Allanson JE, Tartaglia M, Gelb BD: Noonan syndrome. Lancet 2013, 381:333-342.
• [3]Digilio MC, Lepri F, Baban A, Dentici ML, Versacci P, Capolino R, Ferese R, De Luca A, Tartaglia M, Marino B, Dallapiccola B: RASopathies: clinical diagnosis in the first year of life. Mol Syndromol 2011, 1:282-289.
• [4]Cirstea IC, Kutsche K, Dvorsky R, Gremer L, Carta C, Horn D, Roberts AE, Lepri F, Merbitz-Zahradnik T, König R, Kratz CP, Pantaleoni F, Dentici ML, Joshi VA, Kucherlapati RS, Mazzanti L, Mundlos S, Patton MA, Silengo MC, Rossi C, Zampino G, Digilio C, Stuppia L, Seemanova E, Pennacchio LA, Gelb BD, Dallapiccola B, Wittinghofer A, Ahmadian MR, Tartaglia M, et al.: A restricted spectrum of NRAS mutations causes Noonan syndrome. Nat Genet 2010, 42:27-29.
• [5]Martinelli S, De Luca A, Stellacci E, Rossi C, Checquolo S, Lepri F, Caputo V, Silvano M, Buscherini F, Consoli F, Ferrara G, Digilio MC, Cavaliere ML, van Hagen JM, Zampino G, van der Burgt I, Ferrero GB, Mazzanti L, Screpanti I, Yntema HG, Nillesen WM, Savarirayan R, Zenker M, Dallapiccola B, Gelb BD, Tartaglia M: Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype. Am J Hum Genet 2010, 87:250-257.
• [6]Tartaglia M, Gelb BD: Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms. Ann N Y Acad Sci 2010, 1214:99-121.
• [7]Tartaglia M, Gelb BD, Zenker M: Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab 2011, 25:161-179.
• [8]Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, Li L, Yassin Y, Tamburino AM, Neel BG, Kucherlapati RS: Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet 2007, 39:70-74.
• [9]Aoki Y, Niihori T, Banjo T, Okamoto N, Mizuno S, Kurosawa K, Ogata T, Takada F, Yano M, Ando T, Hoshika T, Barnett C, Ohashi H, Kawame H, Hasegawa T, Okutani T, Nagashima T, Hasegawa S, Funayama R, Nagashima T, Nakayama K, Inoue S, Watanabe Y, Ogura T, Matsubara Y: Gain-of-function mutations in RIT1 cause noonan syndrome, a RAS/MAPK pathway syndrome. Am J Hum Genet 2013, 93:173-180.
• [10]Doco-Fenzy M, Mauran P, Lebrun JM, Bock S, Bednarek N, Struski S, Albuisson J, Ardalan A, Collot N, Schneider A, Dastot-Le Moal F, Gaillard D, Goossens M: Pure direct duplication (12)(q24.1→q24.2) in a child with Marcus Gunn phenomenon and multiple congenital anomalies. Am J Med Genet A 2006, 140:212-221.
• [11]Shchelochkov OA, Patel A, Weissenberger GM, Chinault AC, Wiszniewska J, Fernandes PH, Eng C, Kukolich MK, Sutton VR: Duplication of chromosome band 12q24.11q24.23 results in apparent Noonan syndrome. Am J Med Genet A 2008, 146A:1042-1048.
• [12]Graham JM Jr, Kramer N, Bejjani BA, Thiel CT, Carta C, Neri G, Tartaglia M, Zenker M: Genomic duplication of PTPN11 is an uncommon cause of Noonan syndrome. Am J Med Genet A 2009, 149A:2122-2128.
• [13]Luo C, Yang YF, Yin BL, Chen JL, Huang C, Zhang WZ, Wang J, Zhang H, Yang JF, Tan ZP: Microduplication of 3p25.2 encompassing RAF1 associated with congenital heart disease suggestive of Noonan syndrome. Am J Med Genet A 2012, 158A:1918-1923.
• [14]Nowaczyk MJ, Thompson BA, Zeesman S, Moog U, Sanchez-Lara PA, Magoulas PL, Falk RE, Hoover-Fong JE, Batista DA, Amudhavalli SM, White SM, Graham GE, Rauen KA: Deletion of MAP2K2/MEK2: a novel mechanism for a RASopathy? Clin Genet 2013. doi:10.1111/cge.12116. [Epub ahead of print]
• [15]Nava C, Hanna N, Michot C, Pereira S, Pouvreau N, Niihori T, Aoki Y, Matsubara Y, Arveiler B, Lacombe D, Pasmant E, Parfait B, Baumann C, Héron D, Sigaudy S, Toutain A, Rio M, Goldenberg A, Leheup B, Verloes A, Cavé H: Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome. J Med Genet 2007, 44:763-771.
• [16]Chen J, Yang Y, Tan Z, Wang Y, Tang X, Gong Y: Noonan syndrome: a case report and literature review. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009, 34:1261-1265.
• [17]Zhu X, Zhang Y, Wang J, Yang JF, Yang YF, Tan ZP: 576 kb deletion in 1p36.33-p36.32 containing SKI is associated with limb malformation, congenital heart disease and epilepsy. Gene 2013, 528:352-355.
• [18]Bouman A, Schuitema A, Pfundt R, van de Zande G, Kleefstra T: Clinical delineation of a patient with trisomy 12q23q24. Eur J Med Genet 2013, 56:463-469.
• [19]Flex E, Ciolfi A, Caputo V, Fodale V, Leoni C, Melis D, Bedeschi MF, Mazzanti L, Pizzuti A, Tartaglia M, Zampino G: Loss of function of the E3 ubiquitin-protein ligase UBE3B causes Kaufman oculocerebrofacial syndrome. J Med Genet 2013, 50:493-499.
• [20]Lamandé SR, Yuan Y, Gresshoff IL, Rowley L, Belluoccio D, Kaluarachchi K, Little CB, Botzenhart E, Zerres K, Amor DJ, Cole WG, Savarirayan R, McIntyre P, Bateman JF: Mutations in TRPV4 cause an inherited arthropathy of hands and feet. Nat Genet 2011, 43:1142-1146.
• [21]Cordeddu V, Di Schiavi E, Pennacchio LA, Ma'ayan A, Sarkozy A, Fodale V, Cecchetti S, Cardinale A, Martin J, Schackwitz W, Lipzen A, Zampino G, Mazzanti L, Digilio MC, Martinelli S, Flex E, Lepri F, Bartholdi D, Kutsche K, Ferrero GB, Anichini C, Selicorni A, Rossi C, Tenconi R, Zenker M, Merlo D, Dallapiccola B, Iyengar R, Bazzicalupo P, Gelb BD, et al.: Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet 2009, 41:1022-1026.
• [22]Scheidecker S, Etard C, Pierce NW, Geoffroy V, Schaefer E, Muller J, Chennen K, Flori E, Pelletier V, Poch O, Marion V, Stoetzel C, Strähle U, Nachury MV, Dollfus H: Exome sequencing of Bardet-Biedl syndrome patient identifies a null mutation in the BBSome subunit BBIP1 (BBS18). J Med Genet 2013, 51:132-136.
• [23]Tartaglia M, Gelb BD: Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet 2005, 6:45-68.
• [24]Tartaglia M, Zampino G, Gelb BD: Noonan syndrome: clinical aspects and molecular pathogenesis. Mol Syndromol 2010, 1:2-26.
• [25]Sumi M, Ohno Y, Sasaki R, Kondoh T, Tagawa M, Masuzaki H, Moriuchi H: Probable Noonan syndrome in a boy without PTPN11 mutation, manifesting unusual complications. Pediatr Int 2009, 51:138-140.
• [26]Sarkozy A, Digilio MC, Dallapiccola B: Leopard syndrome. Orphanet J Rare Dis 2008, 3:13. BioMed Central Full Text